| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ambrx Biopharma Inc. | Director | Ordinary Shares | 85,000 | $785,800 | $9.24 | 07 Jun 2023 | Direct |
| Ambrx Biopharma, Inc. | Director | Restricted Stock Units | 0 | $0 | $9.82 | 07 Mar 2024 | Direct |
| Ambrx Biopharma, Inc. | Director | Option to Purchase Common Stock | 0 | 07 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024028242-loesberg-janet-2024-03-07 | Ambrx Biopharma, Inc. | 07 Mar 2024 | 3 | $0 | 4 | Director | 07 Mar 2024, 19:19 |
| /report/000089924323015154-loesberg-janet-2023-06-07 | Ambrx Biopharma Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 16:05 |
| /report/000120919123005789-loesberg-janet-2023-01-27 | Ambrx Biopharma Inc. | 27 Jan 2023 | 4 | $0 | 4 | Director | 31 Jan 2023, 17:09 |
| /report/000120919123000415-loesberg-janet-2023-01-01 | Ambrx Biopharma Inc. | 01 Jan 2023 | 0 | $0 | 3 | Director | 03 Jan 2023, 17:28 |